|Articles|April 15, 2014
Almac Receives NY Lab Permit for Trial Enrichment and Companion Diagnostics Development
Almac's diagnostics business unit announced it has received a Clinical Laboratory Permit from the New York State Department of Health
Advertisement
Almac's diagnostics business unit announced it has received a Clinical Laboratory Permit from the New York State Department of Health, allowing Almac's Craigavon, UK-based lab to receive patient samples for clinical testing from New York. Almac has also successfully retained its CAP and CLIA accreditation following an inspection by the College of American Pathologists (CAP).
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
2
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
3
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
4
ACT Brief: Lean Development Through Fractional Teams and Partners, FDA Expedited IND Pilot for Phase I Acceleration, and Tudriqev Accelerated Approval for Anti-PD-1-Refractory Melanoma
5